Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AMERISOURCEBERGEN CORPORATION

(ABC)
  Report
Delayed Nyse  -  21:00:02 01/02/2023 GMT
161.05 USD   -4.68%
02/01AMERISOURCEBERGEN CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
02/01Transcript : AmerisourceBergen Corporation, Q1 2023 Earnings Call, Feb 01, 2023
CI
02/01AmerisourceBergen's Fiscal Q1 Adjusted Earnings, Revenue Increase; Fiscal 2023 Guidance Raised
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/26/2023 01/27/2023 01/30/2023 01/31/2023 02/01/2023 Date
164.91(c) 164.16(c) 165.31(c) 168.96(c) 161.05(c) Last
1 067 295 1 626 610 1 175 801 2 109 091 2 352 102 Volume
+0.89% -0.45% +0.70% +2.21% -4.68% Change
More quotes
Estimated financial data (e)
Sales 2023 252 B - 205 B
Net income 2023 2 118 M - 1 720 M
Net Debt 2023 3 421 M - 2 779 M
P/E ratio 2023 15,9x
Yield 2023 1,21%
Sales 2024 266 B - 216 B
Net income 2024 2 364 M - 1 920 M
Net Debt 2024 2 492 M - 2 024 M
P/E ratio 2024 14,1x
Yield 2024 1,26%
Capitalization 32 570 M 32 570 M 26 458 M
EV / Sales 2023 0,14x
EV / Sales 2024 0,13x
Nbr of Employees 41 500
Free-Float 55,2%
More Financials
Company
AmerisourceBergen Corporation specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services,... 
More about the company
Ratings of AmerisourceBergen Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about AMERISOURCEBERGEN CORPORATION
02/01AMERISOURCEBERGEN CORP Management's Discussion and Analysis of Financial Condition and..
AQ
02/01Transcript : AmerisourceBergen Corporation, Q1 2023 Earnings Call, Feb 01, 20..
CI
02/01AmerisourceBergen's Fiscal Q1 Adjusted Earnings, Revenue Increase; Fiscal 2023 Guidance..
MT
02/01Earnings Flash (ABC) AMERISOURCEBERGEN CORPORATION Posts Q1 Revenue $62.85B, vs. Street..
MT
02/01Earnings Flash (ABC) AMERISOURCEBERGEN CORPORATION Reports Q1 Adjusted EPS $2.71, vs. S..
MT
02/01Amerisourcebergen : Fiscal Q1 Earnings Snapshot
AQ
02/01North American Morning Briefing: Stock Futures -3-
DJ
02/01Amerisourcebergen Corp : Results of Operations and Financial Condition, Regulation FD Disc..
AQ
02/01AmerisourceBergen Reports Fiscal 2023 First Quarter Results
BU
02/01AmerisourceBergen Corporation Declares a Quarterly Cash Dividend, Payable on February 2..
CI
02/01AmerisourceBergen Corporation Reports Earnings Results for the First Quarter Ended Dece..
CI
02/01An unknown buyer acquired Brazil specialty business from AmerisourceBergen Corporation.
CI
01/31Credit Suisse Raises AmerisourceBergen's Price Target to $197 From $182, Keeps Outperfo..
MT
01/31UBS Adjusts AmerisourceBergen Price Target to $190 From $184, Maintains Buy Rating
MT
01/31Evercore ISI Reinstates AmerisourceBergen at Outperform With $185 Price Target
MT
More news
News in other languages on AMERISOURCEBERGEN CORPORATION
02/01Augmentation du bénéfice ajusté et du chiffre d'affaires d'AmerisourceBergen pour le pr..
01/27AmerisourceBergen reçoit une proposition d'actionnaire de Kenneth Steiner
01/26AmerisourceBergen Corporation annonce des départs à la retraite au sein de son conseil ..
01/24Wall Street richting lagere opening
01/24Futures voorspellen lichtrode opening Wall Street
More news
Analyst Recommendations on AMERISOURCEBERGEN CORPORATION
More recommendations
ETFs positioned on AMERISOURCEBERGEN CORPORATIONETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Global Beta Low Beta ETF - USD4.96%-0.85%-NC
VanEck Pharmaceutical ETF - USD4.33%-0.42%United_States
First Trust Consumer Staples AlphaDEX Fund - USD4.28%0.87%United_States
First Trust Dorsey Wright Momentum & Low Vo...2.7%0.29%United_States
Invesco Dynamic Market ETF - USD2.48%2.00%United_States
More ETFs positioned on AMERISOURCEBERGEN CORPORATION
Chart AMERISOURCEBERGEN CORPORATION
Duration : Period :
AmerisourceBergen Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMERISOURCEBERGEN CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 161,05 $
Average target price 181,58 $
Spread / Average Target 12,7%
EPS Revisions
Managers and Directors
Steven H. Collis Senior Vice President
James Francis Cleary Chief Financial Officer & Executive VP
Robert P. Mauch Chief Operating Officer & Executive Vice President
Jennifer E. Dubas Chief Compliance Officer & Senior Vice President
Gina K. Clark Chief Communications & Administration Officer, EVP
Sector and Competitors
1st jan.Capi. (M$)
AMERISOURCEBERGEN CORPORATION-2.81%32 570
ABBOTT LABORATORIES1.85%194 966
MEDTRONIC PLC10.36%114 090
BECTON, DICKINSON AND COMPANY-0.05%72 252
DEXCOM, INC.-4.88%41 604
HOYA CORPORATION8.50%38 000